文献速递消化、代谢与肾脏急症心脑血管急症

2型糖尿病合并超重或肥胖成人的体力活动与体重减轻:Look AHEAD试验的事后分析

Physical Activity and Weight Loss Among Adults With Type 2 Diabetes and Overweight or Obesity: A Post Hoc Analysis of the Look AHEAD Trial.
PubMed 文献 · JAMA Netw Open · 2024-02-05
一句话结论在Look AHEAD加速度计亚组中,维持体重减轻并保持高体力活动与复合心血管终点风险降低61%相关(HR 0.39)。

该研究为Look AHEAD随机临床试验的事后队列分析,纳入美国8个地点1229例2型糖尿病合并超重或肥胖患者,分析前4年体重变化与加速度计测得的体力活动量对心血管复合终点(心血管死亡、非致死性心肌梗死、非致死性卒中或因心绞痛住院)的联合关联。中位随访9.5年,198例(16.1%)发生主要终点。与低体力活动且无体重减轻者相比,维持高体力活动并体重减轻者主要终点风险降低61%(HR 0.39;95%CI 0.19-0.81;P=0.01),体重减轻与体力活动对心血管事件风险的相乘交互作用显著(交互P=0.01)。仅体重减轻或仅高体力活动者主要终点风险无显著差异。作者认为,2型糖尿病合并超重或肥胖人群中,体力活动的心血管获益可能因体重减轻而增强。

要点

  • 在2型糖尿病合并超重或肥胖的Look AHEAD加速度计亚组中,维持体重减轻且高体力活动与主要心血管复合终点风险降低61%相关(HR 0.39;95%CI 0.19-0.81;P=0.01)。
  • 仅体重减轻或仅高体力活动者,主要终点风险与低体力活动且无体重减轻者相比无显著差异。
  • 体重减轻与体力活动对心血管事件风险的相乘交互作用显著(交互P=0.01)。
  • 中位随访9.5年期间,1229例参与者中198例(16.1%)发生主要终点;333例(27%)在前4年达到并维持体重减轻,其中105例(32%)维持高体力活动量。

适用人群与场景

  • Look AHEAD随机临床试验中来自美国8个地点的加速度计测量体力活动亚组参与者,均为2型糖尿病合并超重或肥胖患者。
  • 研究期间为2001年6月至2012年9月,数据分析时间为2023年6月至8月。

研究设计与关键结果

  • 研究类型:Look AHEAD随机临床试验的事后队列分析,共纳入1229例参与者(平均[SD]年龄60[7]岁;男性533例[43%]),来自美国8个地点。
  • 暴露:前4年体重变化与加速度计测得的体力活动量。
  • 主要终点:包括心血管死亡、非致死性心肌梗死、非致死性卒中或因心绞痛住院的复合心血管终点。
  • 随访与事件:中位随访9.5年,198例参与者(16.1%)发生主要终点。
  • 体重减轻:333例(27%)在前4年达到并维持体重减轻;在维持体重减轻者中,105例(32%)维持高体力活动量。
  • 主要结果:与低体力活动且无体重减轻者(105例[15.8%])相比,维持高体力活动并体重减轻者主要终点风险降低61%(HR 0.39;95%CI 0.19-0.81;P=0.01)。
  • 其他比较:仅体重减轻或仅高体力活动者主要终点风险无显著差异。
  • 交互作用:体重减轻与体力活动对心血管事件风险的相乘交互作用显著(交互P=0.01)。

证据类型、等级与局限

  • 证据类型:随机临床试验的事后队列分析(Look AHEAD试验的事后分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,2型糖尿病合并超重或肥胖人群中,体力活动的心血管获益可能因体重减轻而增强。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Prior findings from the Look AHEAD trial showed no significant reduction in the risk of cardiovascular events by lifestyle-induced weight loss among individuals with type 2 diabetes (T2D) and overweight or obesity. However, physical activity (PA) may modify the changes in cardiovascular risk associated with weight loss.

OBJECTIVE: To examine the joint association of weight loss and PA with the risk of adverse cardiovascular events in patients with T2D and overweight or obesity.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study was a post hoc analysis of the Look AHEAD randomized clinical trial, which compared the cardiovascular effects of weight loss by intensive lifestyle intervention vs diabetes support and education among individuals with T2D and overweight or obesity. The study was conducted from June 2001 to September 2012, and participants were patients in the substudy of accelerometry-measured PA from 8 locations in the United States. Data were analyzed from June to August 2023.

EXPOSURES: Body weight change and accelerometer-derived PA volume across the first 4 years.

MAIN OUTCOMES AND MEASURES: The primary outcome was a composite cardiovascular outcome including cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for angina.

RESULTS: Among a total of 1229 participants (mean [SD] age, 60 [7] years; 533 male [43%]), 333 (27%) achieved and maintained weight loss for the first 4 years. Among the individuals who maintained weight loss, 105 (32%) maintained high PA volume. During a median of 9.5 years of follow-up, 198 participants (16.1%) experienced the primary outcome. Compared with those with low PA volume and no weight loss (105 [15.8%]), maintaining high PA volume and weight loss was associated with a 61% lower risk of the primary end point (hazard ratio, 0.39; 95% CI, 0.19-0.81; P = .01). However, there was no significant difference in the risk of the primary end point among those with either weight loss only or high PA only. The multiplicative interaction between weight loss and PA for the risk of cardiovascular events was also significant (P for interaction = .01).

CONCLUSIONS AND RELEVANCE: In this cohort study, maintaining weight loss and higher PA volume was associated with a lower risk of the composite cardiovascular outcome. The findings suggest that the cardiovascular benefits of PA may vary and be enhanced by weight loss among individuals with T2D and overweight or obesity.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Huang Z, Zhuang X, Huang R, et al. Physical Activity and Weight Loss Among Adults With Type 2 Diabetes and Overweight or Obesity: A Post Hoc Analysis of the Look AHEAD Trial. JAMA Netw Open. 2024. PMID: 38386318. doi:10.1001/jamanetworkopen.2024.0219

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。